Add to ORKGOcular myasthenia gravis is a chronic disease generally requiring years of treatment. Treatment consists of either Mestinon or immunosuppressive agents. Many patients with ocular myasthenia gravis are elderly and long term prednisone treatment is fraught with complications. Other immunosuppressive drugs are expensive, take a long time to work or have other complications
Ocular myasthenia gravis (OMG) may produce debilitating diplopia or ptosis leading to significant vi...
BACKGROUND AND PURPOSE: The symptoms of acquired autoimmune ocular myasthenia are restricted to ...
Myasthenia gravis is a chronic disease generally requiring lifelong treatment. Approximately 20% of ...
SUMMARY An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immu...
Immunosuppression is the mainstay of treatment for myasthenia gravis (MG). In this paper, we review ...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
Immunosuppressive therapy for ocular myasthenia gravis (MG) has usually consisted of systemic cortic...
Treatment with chronic corticosteroids has been associated with frequent significant adverse effects...
A 7-year-old girl with ocular myasthenia gravis (MG) refractory to prednisolone and anticholinestera...
The prognosis of myasthenia gravis (MG) has improved dramatically due to advances in critical-care m...
While surgical removal of the thymus gland or a thymoma is often part of the therapy of myasthenia g...
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, due to the binding of...
Myasthenia gravis is the prototype disease among autoantibody derived autoimmune diseases. It genera...
The majority of patients with myasthenia gravis (MG) initially present with ocular symptoms. An unre...
Myasthenia gravis is a disease affecting the neuromuscular junction. Still today it is not very clea...
Ocular myasthenia gravis (OMG) may produce debilitating diplopia or ptosis leading to significant vi...
BACKGROUND AND PURPOSE: The symptoms of acquired autoimmune ocular myasthenia are restricted to ...
Myasthenia gravis is a chronic disease generally requiring lifelong treatment. Approximately 20% of ...
SUMMARY An 8 year old girl with ocular myasthenia gravis was treated with high dose intravenous immu...
Immunosuppression is the mainstay of treatment for myasthenia gravis (MG). In this paper, we review ...
Myasthenia gravis is caused by pathogenic autoantibodies to the postsynaptic neuromuscular junction....
Immunosuppressive therapy for ocular myasthenia gravis (MG) has usually consisted of systemic cortic...
Treatment with chronic corticosteroids has been associated with frequent significant adverse effects...
A 7-year-old girl with ocular myasthenia gravis (MG) refractory to prednisolone and anticholinestera...
The prognosis of myasthenia gravis (MG) has improved dramatically due to advances in critical-care m...
While surgical removal of the thymus gland or a thymoma is often part of the therapy of myasthenia g...
Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction, due to the binding of...
Myasthenia gravis is the prototype disease among autoantibody derived autoimmune diseases. It genera...
The majority of patients with myasthenia gravis (MG) initially present with ocular symptoms. An unre...
Myasthenia gravis is a disease affecting the neuromuscular junction. Still today it is not very clea...
Ocular myasthenia gravis (OMG) may produce debilitating diplopia or ptosis leading to significant vi...
BACKGROUND AND PURPOSE: The symptoms of acquired autoimmune ocular myasthenia are restricted to ...
Myasthenia gravis is a chronic disease generally requiring lifelong treatment. Approximately 20% of ...